Blackstone buys stake in Chinese implant maker

The US private equity firm has invested in China’s fast-growing medical device sector, buying a stake Jiangsu-based Xinrong.

Blackstone buys stake in Chinese implant maker

Blackstone has agreed to make a significant investment into Xinrong Best Medical Instrument, a Chinese maker of orthopaedic implants for trauma, spine and joint applications.

The companies did not state the value of the deal nor the ownership split, however a person familiar with the matter said Blackstone is investing just over $100 million and would have influence over decision-making at the company.

China’s orthopaedic implant market will grow from $1.3 billion...

To continue reading, please login or register for free

Click for more on: china | private equity | acquisitions

Print Edition

FinanceAsia Print Edition

CONFERENCES